Clinical pattern of systemic lupus erythematosus in Western Saudi Arabia

Saudi Medical Journal

Volumn 23, Issue 10, 2002, Pages 1247-1250

  Qari, Faiza A ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; WARFARIN;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CLINICAL LABORATORY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN INJURY; PATIENT INFORMATION; SAUDI ARABIA; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SAUDI ARABIA;

EID: 0036816731     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. A]-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Moussa MM et al. Prevalence of systemic Lupus erythematosus in central Saudi Arabia. Saudi Med J 2002; 23: 87-89.
2. Siddiqui A, Al-Shohaib S, Zawawi T, Richi N. Clinical Pattern of Lupus erythematosus in the western Region of Saudi Arabia. Journal of King Abdul-Aziz University 1994; 4: 79-86.
3. Alballa SR. Systemic Lupus erythematosus in Saudi Patients. Clin Rheumatol 1995; 14: 1-5.
4. Al-Nahdi MS, Al-Mohaya S, Saleh M, Al-Awamy BM, Abdurthman IS. Clinical presentation of Systemic Lupus erythematosus in Saudi patients. Trop Georg Med 1987; 39: 187-190.
5. Al-Nasser NA, Abdul-Ainian GA, Al-Aska AK. Systemic lupus erythematosus in Riyadh, Saudi Arabia. Journal of Riyadh Specialty Hospital 1988; 3: 90-94.
6. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330: 1871-1879.
7. Miller ML. Treatment of systemic Lupus erythematosus. Curr Opin Rheumatol 1992; 4: 693-698.
8. Esdaile JM, Abrahamowicz M, Joseph L. Laboratory tests as predictors of disease exacerbations in SLE. Arthritis Rheum 1996; 39: 370-375.
9. Cerbera R, Khamashta MA, Font J. Morbidity and mortality in systemic Lupus erythematosus during a 5 years period. Medicine 1999; 78: 167-174.
10. Munves EF, Schur PH. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 1983; 26: 848-854.
11. Hochberg MC. Updating the American College of Rheumatology Revised criteria for the classification of systemic Lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1730.
12. Karadsheh MF, Nimir FA, Ajlouni YM, Dneibit WA, Karadsheh RF. The characteristics of systemic Lupus erythematosus. Saudi Med J 2000; 21: 282-286.
13. Samanta A, Feehally J, Roys S, Nichol FE, Sheldon PJ, Walla J. High prevalence of systemic disease and mortality in Asian subjects with systemic Lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
14. Wahl DG, Guillemin F, De-Maistre E, Perret C, Lecompte T, Thibaut G. Risk of venous thrombosis related anti phospholipid antibodies in systemic Lupus erythematosus. Ameta-analysis. Lupus 1997; 6: 467-473.
15. Mosca M, Ruiz-Irasorza G, Khamashta MA, Hughes GR. Treatment of systemic Lupus erythematosus. International Immunopharmacol Journal 2001; 1: 1065-1070.
16. Watanabe T, Sato T, Uchiumi T. Neuropsychiatric manifestations in patients with systemic Lupus erythematosus: Diagnosis and predictive value of longitudinal examination of anti-ribosomal P antibody. Lupus 1996; 5: 178-182.
17. Citera. G, Wilson WA. Ethnic and geographic perspectives in SLE. Lupus 1993; 2: 351-356.
18. Fessler BJ , Boumpas DT. Severe organ involvement in SLE. Diagnosis and management. Rheum Dis Clin North Am 1995; 21: 81-86.
19. Hess EV, Farthey Y. Epidemiology, genetics, etiology, and environment relationships of SLE. Curr Opin Rheumatol 1994; 6: 474-480.
20. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of systemic Lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1275.
21. Nakamura RM, Bylund DJ. Contemporary concepts for clinical and laboratory evaluation of SLE and lupus like syndrome. J Clin Lab Anal 1994; 8: 347-382.
22. Drenkard C, Villa AR, Alarcon-Segovia D, Perez-Vazquez ME. Influence of antiphospholipid antibody syndrome in the survival of patients with SLE. J Rheumatolatol 1994; 21: 1067-1071.
23. Heller CA, Schur PH. Serological and clinical remission in SLE. J Rheumatol 1985; 12: 916-920.
24. Mosca M, Ruiz -Irastorza G, Khamashta MA, Hughes GR. Treatment of systemic Lupus erythematosus. International Immunopharmacol Journal 2001; 16: 1065-1070.
25. Trager J, Ward MM. Mortality and causes of death in systemic Lupus erythematosus. Curr Opin Rheumatol 2001; 13: 345-351.